REPORT ID 2338

United States Nonsteroidal Antiinflammatory Drugs Market Report 2017

Publish Date
8-Dec-17
Pages
100
Format
Electronic (PDF)

In this report, the United States Nonsteroidal Antiinflammatory Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Nonsteroidal Antiinflammatory Drugs in these regions, from 2012 to 2022 (forecast).

United States Nonsteroidal Antiinflammatory Drugs market competition by top manufacturers/players, with Nonsteroidal Antiinflammatory Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi S.A.
    Novartis AG
    GlaxoSmithKline PLC
    Pfizer
    DOMESCO
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Oral
    Injection
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Osteoarthritis
    Muscle Aches
    Backaches
    Dental Pain
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Nonsteroidal Antiinflammatory Drugs Market Report 2017
1 Nonsteroidal Antiinflammatory Drugs Overview
    1.1 Product Overview and Scope of Nonsteroidal Antiinflammatory Drugs
    1.2 Classification of Nonsteroidal Antiinflammatory Drugs by Product Category
        1.2.1 United States Nonsteroidal Antiinflammatory Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Nonsteroidal Antiinflammatory Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Oral
        1.2.4 Injection
    1.3 United States Nonsteroidal Antiinflammatory Drugs Market by Application/End Users
        1.3.1 United States Nonsteroidal Antiinflammatory Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Osteoarthritis
        1.3.3 Muscle Aches
        1.3.4 Backaches
        1.3.5 Dental Pain
        1.3.6 Others
    1.4 United States Nonsteroidal Antiinflammatory Drugs Market by Region
        1.4.1 United States Nonsteroidal Antiinflammatory Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
        1.4.3 Southwest Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
        1.4.5 New England Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
        1.4.6 The South Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
        1.4.7 The Midwest Nonsteroidal Antiinflammatory Drugs Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Nonsteroidal Antiinflammatory Drugs (2012-2022)
        1.5.1 United States Nonsteroidal Antiinflammatory Drugs Sales and Growth Rate (2012-2022)
        1.5.2 United States Nonsteroidal Antiinflammatory Drugs Revenue and Growth Rate (2012-2022)

2 United States Nonsteroidal Antiinflammatory Drugs Market Competition by Players/Suppliers
    2.1 United States Nonsteroidal Antiinflammatory Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Nonsteroidal Antiinflammatory Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Nonsteroidal Antiinflammatory Drugs Average Price by Players/Suppliers (2012-2017)
    2.4 United States Nonsteroidal Antiinflammatory Drugs Market Competitive Situation and Trends
        2.4.1 United States Nonsteroidal Antiinflammatory Drugs Market Concentration Rate
        2.4.2 United States Nonsteroidal Antiinflammatory Drugs Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Nonsteroidal Antiinflammatory Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Nonsteroidal Antiinflammatory Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Region (2012-2017)
    3.2 United States Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Region (2012-2017)
    3.3 United States Nonsteroidal Antiinflammatory Drugs Price by Region (2012-2017)

4 United States Nonsteroidal Antiinflammatory Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Nonsteroidal Antiinflammatory Drugs Revenue and Market Share by Type (2012-2017)
    4.3 United States Nonsteroidal Antiinflammatory Drugs Price by Type (2012-2017)
    4.4 United States Nonsteroidal Antiinflammatory Drugs Sales Growth Rate by Type (2012-2017)

5 United States Nonsteroidal Antiinflammatory Drugs Sales (Volume) by Application (2012-2017)
    5.1 United States Nonsteroidal Antiinflammatory Drugs Sales and Market Share by Application (2012-2017)
    5.2 United States Nonsteroidal Antiinflammatory Drugs Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Nonsteroidal Antiinflammatory Drugs Players/Suppliers Profiles and Sales Data
    6.1 Sanofi S.A.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Nonsteroidal Antiinflammatory Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Novartis AG
        6.2.2 Nonsteroidal Antiinflammatory Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Novartis AG Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GlaxoSmithKline PLC
        6.3.2 Nonsteroidal Antiinflammatory Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.2 Nonsteroidal Antiinflammatory Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 DOMESCO
        6.5.2 Nonsteroidal Antiinflammatory Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 DOMESCO Nonsteroidal Antiinflammatory Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    ...

7 Nonsteroidal Antiinflammatory Drugs Manufacturing Cost Analysis
    7.1 Nonsteroidal Antiinflammatory Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Nonsteroidal Antiinflammatory Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Nonsteroidal Antiinflammatory Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Nonsteroidal Antiinflammatory Drugs Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Nonsteroidal Antiinflammatory Drugs Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Nonsteroidal Antiinflammatory Drugs Sales Volume Forecast by Type (2017-2022)
    11.3 United States Nonsteroidal Antiinflammatory Drugs Sales Volume Forecast by Application (2017-2022)
    11.4 United States Nonsteroidal Antiinflammatory Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer